Author(s): Merry Raphael, Vijayanarayana K, GirishThunga, Karthik Rao N, Sreedharan N

Email(s): vinpharmacol@hotmail.com

DOI: 10.5958/0974-360X.2017.00360.2   

Address: Ms. Merry Raphael1, Dr. Vijayanarayana K2, Dr. GirishThunga3, Dr. Karthik Rao N4, Dr. Sreedharan N2
1Student, Department of Pharmacy Practice, Manipal College of Pharmaceutical Sciences, Manipal University, Manipal, Karnataka, India.
2Associate Professor, Department of Pharmacy Practice, Manipal College of Pharmaceutical Sciences, Manipal University, Manipal, Karnataka, India.
3Assistant Professor, Department of Pharmacy Practice, Manipal College of Pharmaceutical Sciences, Manipal University, Manipal, Karnataka, India.
4Assistant Professor, Department of Medicine, Kasturba Medical College, Manipal University, Manipal, Karnataka, India.
*Corresponding Author

Published In:   Volume - 10,      Issue - 7,     Year - 2017


ABSTRACT:
Background: Diabetes mellitus is a major public-health related problem. The increase in prevalence rates has led to an increase in the economic burden, worldwide. To manage the disease in a better way, Drug utilization research can be used as a strategy to justify the drug therapy. Aims: To study the drug prescribing pattern of anti-diabetic drugs in newly diagnosed type 2 DM patients. Materials and methods: A retrospective observational study was carried out in a tertiary care hospital. As per the study criteria, data was collected from medical records department (MRD) registry using ICD code E 11.9.Data was analysed using SPSS 20.0 and the DDD per 100 bed-days was calculated. Results: A total of 662 patients were newly diagnosed with type 2 DM. The mean age of study population was 52.5 ± 12.5 years and 427(64.5%) patients were male. Hypertension was the most common comorbidity observed in 189 (28.5%) patients. Among the anti-diabetic drugs, the utilization of insulin (0.088 DDDs per 100 bed-days in 2013 and 0.16 DDDs per 100 bed-days in 2014) was highest and among the oral anti-diabetic drugs the utilization pattern of metformin (0.058 DDDs per 100 bed-days in 2013 and 0.071 DDDs per 100 bed-days in 2014) was the highest in both 2013 and 2014. Conclusion: Biguanides (metformin) was highly prescribed anti-diabetic drug in both single and combination drug therapies. This study shows that the treatment pattern of type 2 DM patients is in accordance to the NICE (National Institute for Health and Clinical Excellence) guidelines.


Cite this article:
Merry Raphael, Vijayanarayana K, GirishThunga, Karthik Rao N, Sreedharan N. Utilization Pattern of Anti-Diabetic Drugs in Type 2 Diabetes Mellitus in Tertiary Care Hospital. Research J. Pharm. and Tech. 2017; 10(7): 2063-2068. doi: 10.5958/0974-360X.2017.00360.2


Recomonded Articles:

Author(s): Raj Kumar R, Praveen D, Palani Shanmugasundaram

DOI: 10.5958/0974-360X.2016.00164.5         Access: Open Access Read More

Author(s): Santhosh Kumar V, Praveen D

DOI: 10.5958/0974-360X.2016.00123.2         Access: Open Access Read More

Author(s): Leelavathi D Acharya, N R Rau, N Udupa, Surulivel Rajan M, Vijayanarayana K

DOI: 10.5958/0974-360X.2016.00162.1         Access: Open Access Read More

Author(s): M. Sumithra, Avantika Prabhabanik

DOI: 10.5958/0974-360X.2017.00036.1         Access: Open Access Read More

Author(s): Vaddi Mounika, S. Sarumathy, J. Anisha Ebens, T. S. Shanmugarajan

DOI: 10.5958/0974-360X.2017.00003.8         Access: Open Access Read More

Author(s): Anis Fathima. A. G, Vara Prasanna Rao, P. Shanmugasundaram

DOI: 10.5958/0974-360X.2017.00385.7         Access: Open Access Read More

Author(s): Surendra Nath Pandeya, Rajeev Kumar, Arun Kumar, Ashish Kumar Pathak

DOI: Not Available         Access: Open Access Read More

Author(s): Shikha Batra, Nikhil Batra, Anil Pareek, Badri Prakash Nagori

DOI: Not Available         Access: Open Access Read More

Author(s): Kalaivanan S, Sarumathy S, Anisha Ebens J, Naresh Kumar K, Roobena Parveen A, Nasreen Ashraf M.

DOI: 10.5958/0974-360X.2017.00005.1         Access: Open Access Read More

Author(s): Ranadheer Chowdary P, Praveen. D, Vijey Aanandhi. M

DOI: 10.5958/0974-360X.2017.00086.5         Access: Open Access Read More

Author(s): Sai Chaitanya Raj. B, Gheena Sukumaran

DOI: 10.5958/0974-360X.2015.00216.4         Access: Open Access Read More

Author(s): Krishna Ravi, Rosmi Jose, Sumitha SK, Teena Johny, Krishnaveni K, Shanmuga Sundaram R, Sambath Kumar R

DOI: 10.5958/0974-360X.2017.00490.5         Access: Open Access Read More

Author(s): Pradip Awale, Devendra Sonawane, Sangle Dhananjay, Disha Mhatre, Chetna Misal, Zainab Shaikh, Shamsundar Gulbhile, Santosh Khambatkar, Amit Naik

DOI: Not Available         Access: Open Access Read More

Research Journal of Pharmacy and Technology (RJPT) is an international, peer-reviewed, multidisciplinary journal.... Read more >>>

RNI: CHHENG00387/33/1/2008-TC                     
DOI: 10.5958/0974-360X 

0.38
2018CiteScore
 
56th percentile
Powered by  Scopus


SCImago Journal & Country Rank


Recent Articles




Tags